Skip to main content

Table 4 Health-related quality of life scores by anaemia status in patients with CKD stages 3 and 4 and those on dialysis

From: Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia

Subscales of the KDQOL-36

Non-anaemic

Mean (SD)

Anaemic

Mean (SD)

P-value

Symptoms/problems list

84.9 (15.6)

78.2 (18.0)

<0.0001

Effect of Kidney Disease

78.7 (17.7)

67.0 (21.3)

<0.0001

Burden of Kidney Disease

63.6 (25.7)

49.9 (26.3)

<0.0001

SF-12 physical composite summary

43.1 (9.8)

38.5 (9.9)

<0.0001

 CKD stage 3

45.1 (9.1)

42.3 (9.9)

0.0112

 CKD stage 4

40.6 (10.2)

38.0 (9.5)

0.0506

 Dialysis a

39.5 (10.3)

37.3 (9.8)

0.1319

SF-12 mental composite summary

48.5 (9.1)

45.8 (10.0)

<0.0001

 CKD stage 3

50.6 (8.2)

47.5 (9.5)

0.0028

 CKD stage 4

46.7 (9.3)

45.5 (9.8)

0.2841

 Dialysis a

43.9 (9.1)

45.2 (10.3)

0.3507

  1. Abbreviations: CKD chronic kidney disease, KDQOL-36 Kidney Disease Quality of Life Instrument, SD standard deviation, SF-12, 12-Item Short Form Health Survey
  2. a Note: Anaemia in dialysis patients may be affected by level of erythropoiesis stimulating agent/iron use (78 % of dialysis patients vs 50 % in CKD stage 4 and 19 % in CKD stage 3, respectively)